Literature DB >> 31437510

Computational design of Bacillus licheniformis RN-01 levansucrase for control of the chain length of levan-type fructooligosaccharides.

Pongsakorn Kanjanatanin1, Rath Pichyangkura2, Thassanai Sitthiyotha1, Thanapon Charoenwongpaiboon2, Karan Wangpaiboon2, Surasak Chunsrivirot3.   

Abstract

Levansucrase (LS) from Gram-positive bacteria generally produces a large quantity of levan polymer, a polyfructose with glucose at the end (GFn) but a small quantity of levan-type fructooligosaccharides (LFOs). The properties of levan and LFOs depend on their chain lengths, thereby determining their potential applications in food and pharmaceutical industries such as prebiotics and anti-tumor agents. Therefore, an ability to redesign and engineer the active site of levansucrase for synthesis of products with desired degree of polymerization (DP) is very beneficial. We employed computational protein design, docking and molecular dynamics to redesign and engineer the active site of Bacillus licheniformis RN-01 levansucrase for production of LFOs with DP up to five (GF4), using two approaches: 1) blocking oligosaccharide binding track of GF3-LS complex with large aromatic residues and 2) eliminating hydrogen bond interactions between terminal glucose of GF4 and side chains of binding residues of GF4-LS complex. The designed enzymes and their product patterns from these two approaches were experimentally characterized. The experimental results show that the first approach was successful in creating N251W and N251W/K372Y mutants that synthesized LFOs with DP up to five. This work illustrates how computer-aided approaches can offer novel opportunities to engineer enzymes for desired products.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Docking; Levan; Levansucrase; Molecular dynamics; Oligosaccharides; Protein design

Mesh:

Substances:

Year:  2019        PMID: 31437510     DOI: 10.1016/j.ijbiomac.2019.08.151

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Computational design of Lactobacillus Acidophilus α-L-rhamnosidase to increase its structural stability.

Authors:  Thassanai Sitthiyotha; Methus Klaewkla; Kuakarun Krusong; Rath Pichyangkura; Surasak Chunsrivirot
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

2.  Rational re-design of Lactobacillus reuteri 121 inulosucrase for product chain length control.

Authors:  Thanapon Charoenwongpaiboon; Methus Klaewkla; Surasak Chunsrivirot; Karan Wangpaiboon; Rath Pichyangkura; Robert A Field; Manchumas Hengsakul Prousoontorn
Journal:  RSC Adv       Date:  2019-05-14       Impact factor: 4.036

3.  Levansucrase from Bacillus amyloliquefaciens KK9 and Its Y237S Variant Producing the High Bioactive Levan-Type Fructooligosaccharides.

Authors:  Pongsakorn Phengnoi; Thanapon Charoenwongpaiboon; Karan Wangpaiboon; Methus Klaewkla; Santhana Nakapong; Wonnop Visessanguan; Kazuo Ito; Rath Pichyangkura; Kamontip Kuttiyawong
Journal:  Biomolecules       Date:  2020-04-29

4.  Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.

Authors:  Pornpawee Sookpongthai; Korawich Utayopas; Thassanai Sitthiyotha; Theerakamol Pengsakul; Morakot Kaewthamasorn; Kittikhun Wangkanont; Pongchai Harnyuttanakorn; Surasak Chunsrivirot; Sittiporn Pattaradilokrat
Journal:  Parasit Vectors       Date:  2021-11-08       Impact factor: 3.876

5.  Biochemical and ligand binding properties of recombinant Xenopus laevis cortical granule lectin-1.

Authors:  Peerapon Deetanya; Thassanai Sitthiyotha; Nusara Chomanee; Surasak Chunsrivirot; Kittikhun Wangkanont
Journal:  Heliyon       Date:  2022-08-20

6.  Computational Design of 25-mer Peptide Binders of SARS-CoV-2.

Authors:  Thassanai Sitthiyotha; Surasak Chunsrivirot
Journal:  J Phys Chem B       Date:  2020-11-17       Impact factor: 2.991

7.  Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.

Authors:  Thassanai Sitthiyotha; Surasak Chunsrivirot
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.